Clinical Trial Update: A Study of Bupivacaine Liposome Injection in the Treatment of Pain After Thoracoscopic Surgery [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Bupivacaine Liposome Injection for postoperative pain after thoracoscopic surgery; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Pain

Drugs mentioned

• Bupivacaine Liposome Injection (bupivacaine liposome injectable suspension)

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Local Analgesia Via Nerve Block | Phase 2 | Status: RECRUITING